Bhattacharyya Tapesh, Babu Geethu, Kainickal Cessal Thommachan
Division of Radiation Oncology, Tata Medical Center, Kolkata, India.
Division of Radiation Oncology, Regional Cancer Centre, Trivandrum, India.
J Oncol. 2018 Oct 1;2018:3725837. doi: 10.1155/2018/3725837. eCollection 2018.
Nasopharyngeal carcinoma is highly radio- and chemosensitive tumor with its unique clinical and biological behavior. Treatment of stage I disease is radical radiotherapy alone. For stage II disease treatment is radiotherapy with or without chemotherapy. The standard of care for locally advanced nasopharyngeal cancer (stages III-IVB) is concurrent chemoradiation. Optimum timing and sequence of chemotherapy are not yet well-defined. The role of adjuvant and induction chemotherapy is debatable. Here we are going to highlight the role of chemotherapy in nasopharyngeal carcinoma, its benefit, and controversies regarding timing and sequences.
鼻咽癌是一种对放疗和化疗高度敏感的肿瘤，具有独特的临床和生物学行为。I期疾病的治疗是单纯根治性放疗。II期疾病的治疗是放疗加或不加化疗。局部晚期鼻咽癌（III-IVB期）的标准治疗是同步放化疗。化疗的最佳时机和顺序尚未明确界定。辅助化疗和诱导化疗的作用存在争议。在此，我们将重点阐述化疗在鼻咽癌中的作用、其益处以及关于时机和顺序的争议。
